This morning has proven to be a very exciting morning in the market with news across all categories. Here are some of the biggest moves that we’ve seen in the market today:
Clovis Oncology (NASDAQ: CLVS) – Clovis Oncology is running for the top after the FDA granted priority review for Rubraca. If approved, the drug will be one of very few options in a market that’s worth billions. As such, this could be a blockbuster drug. Read the full story at Alpha Stock News.
Cemtrex Inc (NASDAQ: CETX) – Cemtrex saw serious gains this morning after announcing that it received a $700,000 order for surveillance equipment. The order was substantial as its value was more than 10% of the company’s market cap as of the closing bell yesterday. Read the full story at Alpha Stock News.